Antiphospholipid (aPL) antibodies by themselves are considered to cause autoimmune manifestations of obstetric APS and to react against the domain 1 of β2GPI, a ubiquitous glycoprotein involved in the clearance of apoptotic cells and microparticles [13]. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.